Literature DB >> 11413332

Biologic studies of chimeras of highly and moderately virulent molecular clones of simian immunodeficiency virus SIVsmPBj suggest a critical role for envelope in acute AIDS virus pathogenesis.

M Haddrick1, C R Brown, R Plishka, A Buckler-White, V M Hirsch, H Ginsberg.   

Abstract

Previous studies identified three molecular clones of the acutely pathogenic SIVsmPBj strain that varied in terms of relative in vivo pathogenicity. One clone, SIVsmPBj6.6, reproducibly induced a rapidly fatal disease in pigtailed macaques. In contrast, a highly related clone (SIVsmPBj6.9) was only minimally pathogenic in macaques. PBj6.6 and PBj6.9 shared a tyrosine substitution at position 17 in the Nef protein that is a major determinant of virulence but differed at one residue in Vpx (C89R), three residues within the envelope (D119G, R871G, G872R), and a single residue in Nef (F252L). SIVsmPBj6.9 was less efficient in inducing proliferation of resting macaque peripheral blood mononuclear cells in vitro than SIVsmPBj6.6 and exhibited a marked reduction in infectivity relative to SIVsmPBj6.6. Chimeric viruses for each of these variable residues were constructed, and their biologic properties were compared to those of the parental strains. Differences in Vpx and Nef did not alter the basic biologic phenotype of the chimeras. However, the D119G substitution in the envelope of SIVsmPBj6.9 was associated with a marked reduction in the infectivity of this virus relative to SIVsmPBj6.6. An associated processing defect in gp160 of SIVsmPBj6.9 and chimeras expressing the D119G substitution suggests that a reduction in virion envelope incorporation is the mechanistic basis for reduced virion infectivity. In vivo studies revealed that substitution of the PBj6.9 amino acid into PBj6.6 (D119) abrogated the pathogenicity of this previously pathogenic virus. Introduction of the PBj6.9 G119, however, did not confer full virulence to the parental PBj6.9 virus, implicating one or all of the other four substitutions in the virulence of SIVsmPBj6.6.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11413332      PMCID: PMC114388          DOI: 10.1128/JVI.75.14.6645-6659.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

1.  Indicator cell lines for detection of primary strains of human and simian immunodeficiency viruses.

Authors:  M A Vodicka; W C Goh; L I Wu; M E Rogel; S R Bartz; V L Schweickart; C J Raport; M Emerman
Journal:  Virology       Date:  1997-06-23       Impact factor: 3.616

2.  Costimulatory pathways in lymphocyte proliferation induced by the simian immunodeficiency virus SIVsmmPBj14.

Authors:  L Whetter; F J Novembre; M Saucier; S Gummuluru; S Dewhurst
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

3.  Genetic differences accounting for evolution and pathogenicity of simian immunodeficiency virus from a sooty mangabey monkey after cross-species transmission to a pig-tailed macaque.

Authors:  V Courgnaud; F Lauré; P N Fultz; L Montagnier; C Bréchot; P Sonigo
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

4.  The tyrosine-17 residue of Nef in SIVsmmPBj14 is required for acute pathogenesis and contributes to replication in macrophages.

Authors:  M Saucier; S Hodge; S Dewhurst; T Gibson; J P Gibson; H M McClure; F J Novembre
Journal:  Virology       Date:  1998-05-10       Impact factor: 3.616

5.  Simian-human immunodeficiency virus (SHIV) containing the nef/long terminal repeat region of the highly virulent SIVsmmPBj14 causes PBj-like activation of cultured resting peripheral blood mononuclear cells, but the chimera showed No increase in virulence.

Authors:  E B Stephens; S Mukherjee; Z Q Liu; D Sheffer; R Lamb-Wharton; K Leung; W Zhuge; S V Joag; Z Li; L Foresman; I Adany; O Narayan
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

6.  Postinoculation PMPA treatment, but not preinoculation immunomodulatory therapy, protects against development of acute disease induced by the unique simian immunodeficiency virus SIVsmmPBj.

Authors:  S Hodge; J de Rosayro; A Glenn; I C Ojukwu; S Dewhurst; H M McClure; N Bischofberger; D C Anderson; S A Klumpp; F J Novembre
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

7.  Simian immunodeficiency virus (SIV) envelope-specific Fabs with high-level homologous neutralizing activity: recovery from a long-term-nonprogressor SIV-infected macaque.

Authors:  J Glamann; D R Burton; P W Parren; H J Ditzel; K A Kent; C Arnold; D Montefiori; V M Hirsch
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

8.  Endogenous tumor necrosis factor-alpha contributes to lymphoproliferation induced by simian immunodeficiency virus variant, SIVsmmPBj14.

Authors:  S Hodge; F J Novembre; S Dewhurst
Journal:  Immunol Lett       Date:  1998-08       Impact factor: 3.685

9.  Induction of fas ligand expression by an acutely lethal simian immunodeficiency virus, SIVsmmPBj14.

Authors:  S Hodge; F J Novembre; L Whetter; H A Gelbard; S Dewhurst
Journal:  Virology       Date:  1998-12-20       Impact factor: 3.616

10.  Vpx is required for dissemination and pathogenesis of SIV(SM) PBj: evidence of macrophage-dependent viral amplification.

Authors:  V M Hirsch; M E Sharkey; C R Brown; B Brichacek; S Goldstein; J Wakefield; R Byrum; W R Elkins; B H Hahn; J D Lifson; M Stevenson
Journal:  Nat Med       Date:  1998-12       Impact factor: 87.241

View more
  4 in total

1.  Increased mucosal transmission but not enhanced pathogenicity of the CCR5-tropic, simian AIDS-inducing simian/human immunodeficiency virus SHIV(SF162P3) maps to envelope gp120.

Authors:  Mayla Hsu; Janet M Harouse; Agegnehu Gettie; Clarisa Buckner; James Blanchard; Cecilia Cheng-Mayer
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

Review 2.  Primate immunodeficiency virus classification and nomenclature: Review.

Authors:  Brian T Foley; Thomas Leitner; Dimitrios Paraskevis; Martine Peeters
Journal:  Infect Genet Evol       Date:  2016-10-24       Impact factor: 3.342

3.  Comparison of simian immunodeficiency virus SIVagmVer replication and CD4+ T-cell dynamics in vervet and sabaeus African green monkeys.

Authors:  Simoy Goldstein; Charles R Brown; Ilnour Ourmanov; Ivona Pandrea; Alicia Buckler-White; Christopher Erb; Jayashree S Nandi; Gabriel J Foster; Patrick Autissier; Jörn E Schmitz; Vanessa M Hirsch
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

4.  The ITAM in Nef influences acute pathogenesis of AIDS-inducing simian immunodeficiency viruses SIVsm and SIVagm without altering kinetics or extent of viremia.

Authors:  Houman Dehghani; Charles R Brown; Ronald Plishka; Alicia Buckler-White; Vanessa M Hirsch
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.